Ascendia Pharmaceutical Solutions Puts Customers First During Formulation Development & Manufacturing

May 18, 2026 2:50:25 PM

How Nanoparticle Technologies Aid Ocular Drug Delivery

Apr 20, 2026 2:22:43 PM

PROTACS – A New Generation of Poorly Soluble and Permeable Molecules for Targeting Proteins

Mar 4, 2026 12:45:33 PM

Long-Acting Injectable Drugs: How Nanoparticles Help Overcome Challenges

Feb 16, 2026 4:56:24 PM

PLGA: A Versatile Copolymer for Nanoparticle Design & Development

Jan 2, 2026 5:29:48 PM

Overcoming Oral Drug Development Challenges

Dec 11, 2025 2:52:40 PM

Spray Drying Addresses Poorly Soluble NME Challenges to Optimize Drug Development

Nov 17, 2025 7:06:45 PM

Ascendia Pharmaceutical Solutions Provides Forum to Advance Drug Development

Oct 30, 2025 3:40:54 PM

All GRAS Materials: The Hidden Advantage in Speed, Quality, and Compliance

Oct 13, 2025 9:05:17 PM

Hot Melt Extrusion – An Enabling Technology for Poorly Soluble Drugs

Oct 9, 2025 12:59:29 PM

Ascendia Pharmaceutical Solutions to Attend the Contract Pharma Conference

Sep 5, 2025 11:26:30 AM

Ascendia Pharmaceutical Solutions to Host 3rd Annual Technical Workshop to Advance Drug Development

Sep 4, 2025 5:31:19 PM